Acute cardiac resynchronization therapy for right ventricular disease

Acute cardiac resynchronization therapy for right ventricular disease - Resynchronization therapy for right ventricular disease

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON32199

Enrollment

Registered

2008-05-27

Start date

2008-02-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary hypertension

Interventions

acute cardiac resynchronization therapy (CRT), i.e., temporary right atrial and right ventricular pacing immediately after routine right heart catheterization

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Adult CTEPH patients who undergo right heart catheterization to obtain hemodynamic data as part of the regular diagnostic workup to assess their eligibility for pulmonary endarterectomy

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Primary: the reduction (in msec) of right-to-left delay in onset of diastole following acute CRT as measured using tissue Doppler echocardiography.	—

Secondary

Measure	Time frame
Secondary: the improvement (in l/min) of cardiac output following acute CRT as measured using pressure-conductance measurements in the left ventricle and noninvasive FinaPress*, and the improvement of microcirculation following acute CRT as measured using noninvasive SDF.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)